Custom DNA oligos, ssodn, gblocks, sgrnas, CAS9, to support the research focuses on cellular and molecular mechanisms of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), two…
Ended Awarded
- Contract number
- 75N95A25F00001
- Awardee
-
Integrated DNA Technologies, Inc. UEI P55FTN1UMYZ1
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,000
Award facts
- Contract value 100% obligated
- $10,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325199 All Other Basic Organic Chemical Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Coralville, IA 52241, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm-fixed-price Blanket Purchase Agreement (BPA) contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), to Integrated DNA Technologies, Inc. (IDT). The $10,000 contract provides custom DNA oligonucleotides, single-stranded DNA, gBlocks, small guide RNAs, and Cas9 enzyme to support NINDS research on the cellular and molecular mechanisms of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), two related neurodegenerative disorders.
IDT, a leading provider of specialized nucleic acid products and services to the federal government, will deliver these research materials under the contract. This award is not set aside for any specific business type. IDT also holds a $100 million NIH BPA and a $2.5 million Department of Veterans Affairs Federal Supply Schedule contract to provide a wide range of oligonucleotides, reagents, and services to support federal biomedical and genomics research initiatives.
Description
Custom DNA oligos, ssodn, gblocks, sgrnas, CAS9, to support the research focuses on cellular and molecular mechanisms of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), two related neurodegenerative disorders.
Quick answers
Who was awarded contract 75N95A25F00001?
75N95A25F00001 was awarded to Integrated DNA Technologies, Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on March 20, 2025.
How much is contract 75N95A25F00001 worth?
The government has obligated $10,000 on 75N95A25F00001.
Is contract 75N95A25F00001 an order under another contract?
Yes. 75N95A25F00001 is a BPA call under 75N98024A00173, a blanket purchase agreement.
Was contract 75N95A25F00001 competed?
The extent of competition for 75N95A25F00001 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award